Effect of intranasal dexmedetomidine on emergence agitation

Effect of intranasal dexmedetomidine on emergence agitation after sevoflurane anesthesia in children undergoing tonsillectomy and/ or adenoidectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201604001572340

Enrollment

Registered

2016-04-07

Start date

2015-10-07

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ear, Nose and Throat Surgery Paediatrics

Interventions

Group D

group C

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA I and II physical status. Ages ranged between 3-7 years old. Scheduled for an elective tonsillectomy and/ or adenoidectomy under general anaesthesia with sevoflurane.

Exclusion criteria

Exclusion criteria: Obstructive sleep apnea. Mental retardation or developmental delay. Chest, cardiac or neurological diseases. Known allergy or hypersensitivity to dexmedetomidine. Patients receiving medications known to interact with dexmedetomidine such as furosemide, lorazepam, and diphenhydramine

Design outcomes

Primary

Measure	Time frame
Four-point agitation scale	—

Secondary

Measure	Time frame
FLACC scale score for pain assessment were measured at six-time points ;Adverse effects	—

Countries

Egypt

Contacts

Public ContactHany Mahmoud Yassin

Lecturer

hmy00@fayoum.edu.eg+201111363602

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026